Mallinckrodt has finally claimed FDA approval for terlipressin as a treatment for hepatorenal syndrome (HRS), after manufacturing problems scuppered an earlier attempt. Terlipressin – now given the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback